SE9502926D0 - Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it - Google Patents

Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it

Info

Publication number
SE9502926D0
SE9502926D0 SE9502926A SE9502926A SE9502926D0 SE 9502926 D0 SE9502926 D0 SE 9502926D0 SE 9502926 A SE9502926 A SE 9502926A SE 9502926 A SE9502926 A SE 9502926A SE 9502926 D0 SE9502926 D0 SE 9502926D0
Authority
SE
Sweden
Prior art keywords
anergy
hiv
vaccines
peptides
drugs
Prior art date
Application number
SE9502926A
Other languages
Swedish (sv)
Inventor
Jonas Blomberg
Ruediger Pipkorn
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9502926A priority Critical patent/SE9502926D0/en
Publication of SE9502926D0 publication Critical patent/SE9502926D0/en

Links

SE9502926A 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it SE9502926D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9502926A SE9502926D0 (en) 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502926A SE9502926D0 (en) 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it

Publications (1)

Publication Number Publication Date
SE9502926D0 true SE9502926D0 (en) 1995-08-24

Family

ID=20399260

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502926A SE9502926D0 (en) 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it

Country Status (1)

Country Link
SE (1) SE9502926D0 (en)

Similar Documents

Publication Publication Date Title
ZA964694B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
ITRM930591A0 (en) MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR DRUGS AT VERY LOW DOSES, IN PARTICULAR HOMEOPATHIC DRUGS.
CY1106152T1 (en) NEW ANTI-HIV IMMUNE (ANTITOXINS), PREPARATION METHODS AND APPLICATION IN THE PREVENTION AND TREATMENT OF AIDS
ZA964680B (en) Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.
NL7702784A (en) PROCESS FOR THE PURIFICATION AND ISOLATION OF HE PATITIS VIRUS FOR USE IN THE PREPARATION OF A VACCINE.
GB2255093A (en) Hiv-1 core protein fragments
IL107262A0 (en) Oral vaccines comprising multiple emulsions and methods of preparation
EE04371B1 (en) Phenylamidine derivatives, processes for their preparation and their use in medicine
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
IT1318365B1 (en) PROTECTION DEVICE FOR NEEDLE FOR SYRINGE FOR MEDICAL USE.
EP0437729A3 (en) New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses
SE9502926D0 (en) Epitope specific B-cell anergy in HiV infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and drugs to prevent and treat it
RU98111152A (en) The use of the active substance flupirtine or its pharmacologically acceptable salts as a drug for the prevention and treatment of diseases associated with damage to the cell system
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
HUP0100937A2 (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
DE69130571D1 (en) Peptides that inhibit human immunodeficiency virus and how to use it
IT1276509B1 (en) VACCINE FOR THE IMMUNE PROPHYLAXY OF FELINE IMMUNODEFICIENCY VIRUS INFECTION OF DOMESTIC CAT.
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
BR0112874A (en) Use of fribrates for the preparation of a drug useful in the treatment of congestive heart failure.
Highleyman Major vaccine trials begin
RU93016671A (en) IMMUNODULATOR
FR2735694B1 (en) CLADINOSIS AS A MEDICINAL PRODUCT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Hecht A new focus on primary HIV infection
James Restoring HIV-specific immunity
TNSN03066A1 (en) Natural antibodies active against hiv virus